Indivior PLC (INDV) continued its winning streak, jumping 16.09% to close at $20.20 on Thursday after reporting a net income of $18 million in the second quarter, a significant improvement from last year’s $97 million net loss. Net revenues increased by 1% to $302 million, driven by strong sales of its Sublocade drug. For the first half, the company recorded a $65 million net profit, with revenues dipping by 2.6% to $568 million. Following these results, Indivior raised its net revenue guidance for full year 2025 to a range of $1.03 billion to $1.08 billion.

Read more at Yahoo Finance: Indivior (INDV) Extends Jump on 3rd Day with 16% Gain